DEF 14AThe Ballot
Spyre Therapeutics, Inc. files DEF 14A
Filed Apr 10, 2026 · 2mo ago · Accession 0001636282-26-000039
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Spyre Therapeutics, Inc.
- Ticker
- SYRE
- CIK
- 1636282
- Form type
- DEF 14A
- Filing date
- Apr 10, 2026
- Report date
- May 27, 2026
- Document
- syre-20260410.htm
- Size
- 5.0 MB